Reed Smith’s Life Sciences Health Industry Group is pleased to offer a full-day CLE program covering hot topics and emerging litigation trends for in-house counsel at pharmaceutical and medical device companies.

Speakers: Thomas H. Suddath Divonne Smoyer Ann V. Kramer José Astigarraga Marilyn A. Moberg Eric L. Alexander Gerard M. Stegmaier Nancy Bonifant Halstead Barbara R. Binis Michael J. Salimbene, James M. Beck Rachel B. Weil Heather A. Ritch Rocks Rudolf E. Hutz

Event Type: CLE / CPD, Seminar

Location Name:
Reed Smith's Philadelphia Office, Three Logan Square 1717 Arch Street, 31st Floor, Philadelphia PA 19103
Start Date/Time:
2 November 2017, 8:30 AM EDT
End Date/Time:
2 November 2017, 4:00 PM EDT

The day will feature sessions on:

  • Government Regulatory Enforcement: Updates And Strategies
  • Lessons Learned In International Arbitration Battles
  • Digital Health: Issues and Considerations with Patient Engagement, Connected Devices, and Integrated Data
  • Product Liability Jury Trials: Trends and Recent Angles of Attack
  • Going Long: Addressing the Biggest Opportunities and Threats in Prescription Medical Product Liability Litigation
  • Jurisdiction and Venue Refresh Courtesy of Bristol-Myers and TC Heartland

It will also include a networking breakfast and lunch; a networking reception will immediately follow at 4 p.m.

Reed Smith is an accredited CLE provider in New Jersey and Pennsylvania. This course is presumptively approved for 7.2 CLE credits in New Jersey and 6 CLE credits Pennsylvania. An application for Delaware credit is pending. For lawyers licensed in New York, this course is eligible for 7 credits under New York’s Approved Jurisdiction Policy.

In-house counsel at pharmaceutical or medical device companies interested in attending should contact their Reed Smith relationship partner or Elizabeth Starrantino to register.